Capricor Therapeutics CAPR Operating margin
Operating margin at other companies
Other financials
Where this comes from
Calculated from Capricor Therapeutics’s reported figures.
Based on trailing twelve months.
The official record: Capricor Therapeutics’s 10-Q, filed November 10, 2025, on SEC EDGAR. View the filing →
Ask your AI about Capricor Therapeutics's operating margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Capricor Therapeutics's operating margin?
- Capricor Therapeutics (CAPR) reported operating margin of -778.8% in Q3 2025.
- How has Capricor Therapeutics's operating margin changed year-over-year?
- Capricor Therapeutics's operating margin decreased by 400.4% year-over-year, from -155.6% to -778.8%.
- What is the long-term trend for Capricor Therapeutics's operating margin?
- Over 2 years (2020 to 2024), Capricor Therapeutics's operating margin has grown at a -79.2% compound annual growth rate (CAGR), from -4,412.6% to -191.1%.
- What does operating margin mean?
- Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.